Novel drug MLC901 underperforms against cognitive decline
16 Apr 2021
byTristan Manalac
NEURoaid II (MLC901), a traditional Chinese medicine-based neuroprotective intervention under investigation, is safe to administer in patients with vascular cognitive impairment no dementia (VCIND), but does not seem to grant significant cognitive benefits, according to a recent Singapore study.